Neural-network selection of high-redshift radio quasars, and the luminosity function at z~4

We obtain a sample of 87 radio-loud QSOs in the redshift range 3.6<z<4.4 by cross-correlating sources in the FIRST radio survey S{1.4GHz} > 1 mJy with star-like objects having r <20.2 in SDSS Data Release 7. Of these 87 QSOs, 80 are spectroscopically classified in previous work (mainly SDSS), and form the training set for a search for additional such sources. We apply our selection to 2,916 FIRST-DR7 pairs and find 15 likely candidates. Seven of these are confirmed as high-redshift quasars, bringing the total to 87. The candidates were selected using a neural-network, which yields 97% completeness (fraction of actual high-z QSOs selected as such) and an efficiency (fraction of candidates which are high-z QSOs) in the range of 47 to 60%. We use this sample to estimate the binned optical luminosity function of radio-loud QSOs at $z\sim 4$, and also the LF of the total QSO population and its comoving density. Our results suggest that the radio-loud fraction (RLF) at high z is similar to that at low-z and that other authors may be underestimating the fraction at high-z. Finally, we determine the slope of the optical luminosity function and obtain results consistent with previous studies of radio-loud QSOs and of the whole population of QSOs. The evolution of the luminosity function with redshift was for many years interpreted as a flattening of the bright end slope, but has recently been re-interpreted as strong evolution of the break luminosity for high-z QSOs, and our results, for the radio-loud population, are consistent with this.Comment: 20 pages. Accepted for publication in MNRAS on 3 March 201

Optimization of the Efficiency in a Syngas Powered Si Engine Through Numerical Studies Related to the Geometry of the Combustion Chamber

The combustion process occurring in an alternative Spark Ignition (SI) engine powered with bio-syngas from biomass gasification was previously studied by authors through the development of two different numerical models: a 0-1D model developed in the GT-Suite® environment, aimed at gaining a first look upon the main features of the heat release by the syngas and engine performances; a 3D Computational Fluid Dynamics (CFD) model developed within the AVL FireTM software reproducing the engine combustion cycle within a Reynolds Averaged Navier Stokes (RANS) schematization and employing a detailed chemical reaction mechanism to highlight the interaction between the fluid dynamics and the kinetics of the specific biofuel oxidation chain. The numerical results were validated with respect to experimental measurements in a baseline condition, where the presence of a relatively high amount of CO in the exhaust gases was noticed as related to an engine low combustion efficiency, mainly due to the peripheral spark plug position that determines the persistence of residual gases on the opposite side of the combustion chamber wall. The proposed work presents a numerical analysis made through the developed models on the effects of proper changes in the spark plug position. A multi-objective optimization problem is conducted also by varying the Start of Spark (SOS) and the mixture air-to-fuel ratio with the aim of reducing the engine environmental impact without affecting its performances. A centrally mounted spark, along with a correct calibration of the SOS and mixture ratio, allows a reduction of more than 90% of CO emission with respect to the baseline condition without penalizing the engine brake power and efficienc

Conceptual Design of a Variable Geometry, Axial Flow Turbocharger Turbine

The modern automotive industry is under strict regulations to reduce emissions to comply with the Kyoto Protocol, a universally acknowledged treaty aiming at reducing exhaust gas emissions. In order to achieve the required future emission reduction targets, further developments on gasoline engines are required. One of the main methods to achieve this goal is the application of engine downsizing. Turbocharging is a cost-effective method of downsizing an engine whilst reducing exhaust gas emissions, reducing fuel consumption and maintaining prior performance outputs. For these reasons, the turbocharging is becoming the most widely adopted technology in the automotive markets. In 2012, 32% of passenger and commercial vehicles sold had a turbocharger installed, and is predicted to be 40% of 2017 [1]. Even if the engine turbocharging is a widespread technology, there are still drawbacks present in current turbocharging systems. The main problem is overcoming the issue of turbo-lag, which is the poor initial response of the turbocharger to the driver commands due to its inertia. Indeed, the system turbine plus compressor is characterized by an own rotational inertia, therefore, the turbocharger will take a certain time to accelerate and produce the desired boost when a higher amount of exhaust gas is sent to the system. In this work, an innovative solution to the turbo-lag phenomenon will be analyzed: a vaneless stator-axial flow turbine. The proposed turbine configuration would improve the transient response of the system since the axial turbine has intrinsically a lower inertia than the radial turbine as stated by the research works of Ford first [2] and Honeywell after [3]. The whole design process is presented in this paper and particular relevance has been given to the thermo-fluid-dynamic aspect of the machine. Several CFD investigations have been carried out in order to deeply understand the new turbine behavior and, thanks to a 1D model of the target engine, it has been possible to validate the new design simulating the performance of the system engine + turbocharger

A multichannel reflectometer for edge density profile measurements at the ICRF antenna in ASDEX upgrade

A multichannel reflectometer will be built for the new three-straps ICRF antenna of ASDEX Upgrade (AUG), to study the density behavior in front of it. Ten different accesses to the plasma are available for the three reflectometer channels that can be interchanged without breaking the machine vacuum. Frequency is scanned from 40 GHz to 68 GHz, in 10 mu s, which corresponds to a cut-off density ranging from 10(18) divided by 10(19)m(-3) in the Right cut-off of the X-mode propagation, for standard toroidal magnetic field values of AUG

A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated to the covid-19 vaccine administration

Globally, at the time of writing (20 March 2021), 121.759.109 confirmed COVID-19 cases have been reported to the WHO, including 2.690.731 deaths. Globally, on 18 March 2021, a total of 364.184.603 vaccine doses have been administered. In Italy, 3.306.711 confirmed COVID-19 cases with 103.855 deaths have been reported to WHO. In Italy, on 9 March 2021, a total of 6.634.450 vaccine doses have been administered. On 15 March 2021, Italian Medicines Agency (AIFA) decided to temporarily suspend the use of the AstraZeneca COVID-19 vaccine throughout the country as a precaution, pending the rulings of the European Medicines Agency (EMA). This decision was taken in line with similar measures adopted by other European countries due to the death of vaccinated people. On 18 March 2021, EMA’s safety committee concluded its preliminary review about thromboembolic events in people vaccinated with COVID-19 Vaccine AstraZeneca at its extraordinary meeting, confirming the benefits of the vaccine continue to outweigh the risk of side effects, however, the vaccine may be associated with very rare cases of blood clots associated with thrombocytopenia, i.e., low levels of blood platelets with or without bleeding, including rare cases of cerebral venous thrombosis (CVT). We report the case of a 54-year-old woman who developed disseminated intravascular coagulation (DIC) with multi-district thrombosis 12 days after the AstraZeneca COVID-19 vaccine administration. A brain computed tomography (CT) scan showed multiple subacute intra-axial hemorrhages in atypical locations, including the right frontal and the temporal lobes. A plain old balloon angioplasty (POBA) of the right coronary artery was performed, without stent implantation, with restoration of distal flow, but with persistence of extensive thrombosis of the vessel. A successive thorax angio-CT added the findings of multiple contrast filling defects with multi-vessel involvement: at the level of the left upper lobe segmental branches, of left interlobar artery, of the right middle lobe segmental branches and of the right interlobar artery. A brain magnetic resonance imaging (MRI) in the same day showed the presence of an acute basilar thrombosis associated with the superior sagittal sinus thrombosis. An abdomen angio-CT showed filling defects at the level of left portal branch and at the level of right suprahepatic vein. Bilaterally, it was adrenal hemorrhage and blood in the pelvis. An evaluation of coagulation factors did not show genetic alterations so as the nasopharyngeal swab ruled out a COVID-19 infection. The patient died after 5 days of hospitalization in intensive care

Implementation of the new multichannel X-mode edge density profile reflectometer for the ICRF antenna on ASDEX Upgrade

A new multichannel frequency modulated continuous-wave reflectometry diagnostic has been successfully installed and commissioned on ASDEX Upgrade to measure the plasma edge electron density profile evolution in front of the Ion Cyclotron Range of Frequencies (ICRF) antenna. The design of the new three-strap ICRF antenna integrates ten pairs (sending and receiving) of microwave reflectometry antennas. The multichannel reflectometer can use three of these to measure the edge electron density profiles up to 2 x 10(19) m(-3), at different poloidal locations, allowing the direct study of the local plasma layers in front of the ICRF antenna. ICRF power coupling, operational effects, and poloidal variations of the plasma density profile can be consistently studied for the first time. In this work the diagnostic hardware architecture is described and the obtained density profile measurements were used to track outer radial plasma position and plasma shape

Platelet aggregation is affected by nitrosothiols in patients with chronic hepatitis: in vivo and in vitro studies

AIM: To investigate the relationship among the number of platelets and plasma levels of S-nitrosothiols (S-NO), nitrite, total non-protein SH (NPSH), glutathione (GSH), cysteine (CYS), malondialdehyde (MDA), 4-hydroxininenal (4HNE), tumor necrosis factor-alpha (TNFalpha) and interleukin (IL)-6 in patients with chronic hepatitis C (CH). METHODS: In vitro the aggregation of platelets derived from controls and CH patients was evaluated before and after the addition of adenosine diphosphate (ADP) and collagen, both in basal conditions and after incubation with nitrosoglutathione (GSNO). RESULTS: In vivo, S-NO plasma levels increased significantly in CH patients and they were significantly directly correlated with platelet numbers. Patients with platelet counts 150000/microL. In vitro, the ADP and collagen aggregation time was increased in platelets from patients and not from controls; in addition, platelets from CH patients but not from controls also showed a latency time after exposure to collagen

A new hexapeptide from the leader peptide of rMnSOD enters cells through the oestrogen receptor to deliver therapeutic molecules

A 24-amino acid leader peptide of a new human recombinant manganese superoxide dismutase can enter cells and carry molecules. Here, we demonstrated that six of the 24 amino acids penetrate cells through a particular gate represented by a specific amino acid sequence of the oestrogen receptor (ER). We analysed the internalization of the synthetic hexapeptide and the cytotoxic activity of the hexapeptide conjugated to cisplatin on a cell line panel. In most cell lines, the hexapeptide delivered an amount of cisplatin that was 2 to 8 times greater than that released by cisplatin when the drug was used alone. This increased delivery increases the therapeutic index of cisplatin and reduces side effects caused by a high dosage or long-term treatment times. We may consider this hexapeptide a new molecular carrier to deliver molecules with therapeutic activity into ER+ cells for diagnostic purposes and clinical or immune therapy